Literature DB >> 33999333

Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications.

Yao Tang1, Xiusheng He2.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies. It has obvious ethnic and regional specificity. Long non-coding RNAs (LncRNAs) are a class of non-protein coding RNA molecules. Emerging research shows that lncRNAs play a key role in tumor development, prognosis, and treatment. With the deepening of sequence analysis, a large number of functional LncRNAs have been found in NPC, which interact with coding genes, miRNAs, and proteins to form a complex regulatory network. However, the specific role and mechanism of abnormally expressed lncRNAs in the pathogenesis of NPC is not fully understood. This article briefly introduced the concept, classification, and functional mechanism of lncRNAs and reviewed their biological functions and their clinical applications in NPC. Specifically, we described lncRNAs related to the occurrence, growth, invasion, metastasis, angiogenesis, and cancer stem cells of NPC; discussed lncRNAs related to Epstein-Barr virus infection; and summarized the role of lncRNAs in NPC treatment resistance. We have also sorted out lncRNAs related to Chinese medicine treatment. We believe that with the deepening of lncRNAs research, tumor-specific lncRNAs may become a new target for the treatment and a biomarker for predicting prognosis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biological functions; Clinical applications; Long non-coding RNAs (lncRNAs); Nasopharyngeal carcinoma (NPC)

Year:  2021        PMID: 33999333     DOI: 10.1007/s11010-021-04176-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  126 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 2.  The functions and unique features of long intergenic non-coding RNA.

Authors:  Julia D Ransohoff; Yuning Wei; Paul A Khavari
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-15       Impact factor: 94.444

3.  MEG3 imprinted gene contribution in tumorigenesis.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

4.  lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition.

Authors:  Nian Jiang; Xuedi Wang; Xianbiao Xie; Yan Liao; Ni Liu; Junfeng Liu; Nabo Miao; Jingnan Shen; Tingsheng Peng
Journal:  Cancer Lett       Date:  2017-06-19       Impact factor: 8.679

5.  A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.

Authors:  Xun Zhang; Yunli Zhou; Kshama R Mehta; Daniel C Danila; Staci Scolavino; Stacey R Johnson; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 6.  Cellular functions of long noncoding RNAs.

Authors:  Run-Wen Yao; Yang Wang; Ling-Ling Chen
Journal:  Nat Cell Biol       Date:  2019-05-02       Impact factor: 28.824

7.  Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.

Authors:  Yefeng Ji; Guanying Feng; Yunwen Hou; Yang Yu; Ruixia Wang; Hua Yuan
Journal:  Cancer Med       Date:  2020-04-11       Impact factor: 4.452

8.  Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Ting Han; Meng Zhuo; Cuncun Yuan; Xiuying Xiao; Jiujie Cui; Guangrong Qin; Liwei Wang; Feng Jiao
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

9.  Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.

Authors:  Yong Wang; Xiandong Zeng; Ningning Wang; Wei Zhao; Xi Zhang; Songling Teng; Yueyan Zhang; Zhi Lu
Journal:  Mol Cancer       Date:  2018-05-12       Impact factor: 27.401

10.  The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.

Authors:  Ke-Jing Zhang; Xiao-Lang Tan; Lei Guo
Journal:  Mol Oncol       Date:  2020-01-10       Impact factor: 6.603

View more
  5 in total

Review 1.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

2.  Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.

Authors:  Ning Jiang; Lijun Zhao; Dan Zong; Li Yin; Lirong Wu; Cheng Chen; Xue Song; Qian Zhang; Xuesong Jiang; Xia He; Jifeng Feng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell.

Authors:  Yanfei Li; Zhenpeng Liao; Rong Wang; Zibin Liang; Zhihe Lin; Shiqi Deng; Lei Chen; Zhigang Liu; Shaoyan Feng
Journal:  PeerJ       Date:  2022-03-30       Impact factor: 2.984

4.  Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.

Authors:  Yian Wang; Qijia Yan; Yongzhen Mo; Yuhang Liu; Yumin Wang; Shanshan Zhang; Can Guo; Fuyan Wang; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2022-02-28       Impact factor: 27.401

5.  LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma.

Authors:  Shuo Li; Mingxing Tang; Nan Zen; Junyi Liang; Xiao Xing; Danglin Huang; Fei Liu; Xiaomeng Zhang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.